Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Outlook Therapeutics
(41O.F) Q2 2026
Earnings
41O.F
May 15
Confirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-0.38
-0.27
-0.16
-0.05
Details
Expected EPS
-0.10422664173
Actual EPS
-0.1376304
Surprise EPS
-0.03
Surprise Percent
-32.05%
Description
Outlook Therapeutics (41O.F) has reported earnings of -0.1376304 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login